164 related articles for article (PubMed ID: 23681188)
1. The impact of comorbidity and stage on prognosis of Danish melanoma patients, 1987-2009: a registry-based cohort study.
Grann AF; Frøslev T; Olesen AB; Schmidt H; Lash TL
Br J Cancer; 2013 Jul; 109(1):265-71. PubMed ID: 23681188
[TBL] [Abstract][Full Text] [Related]
2. Aspects of survival from colorectal cancer in Denmark.
Iversen LH
Dan Med J; 2012 Apr; 59(4):B4428. PubMed ID: 22459726
[TBL] [Abstract][Full Text] [Related]
3. The impact of comorbidity and stage on ovarian cancer mortality: a nationwide Danish cohort study.
Tetsche MS; Dethlefsen C; Pedersen L; Sorensen HT; Norgaard M
BMC Cancer; 2008 Jan; 8():31. PubMed ID: 18230177
[TBL] [Abstract][Full Text] [Related]
4. Does comorbidity interact with colorectal cancer to increase mortality? A nationwide population-based cohort study.
Erichsen R; Horváth-Puhó E; Iversen LH; Lash TL; Sørensen HT
Br J Cancer; 2013 Oct; 109(7):2005-13. PubMed ID: 24022185
[TBL] [Abstract][Full Text] [Related]
5. A Cohort Study: Comorbidity and Stage Affected the Prognosis of Melanoma Patients in Taiwan.
Chang CK; Hsieh YS; Chen PN; Chu SC; Huang JY; Wang YH; Wei JC
Front Oncol; 2022; 12():846760. PubMed ID: 35311079
[TBL] [Abstract][Full Text] [Related]
6. Survival in familial colorectal cancer: a Danish cohort study.
Lautrup CK; Mikkelsen EM; Lash TL; Katballe N; Sunde L
Fam Cancer; 2015 Dec; 14(4):553-9. PubMed ID: 25963853
[TBL] [Abstract][Full Text] [Related]
7. Hospital-based herpes zoster diagnoses in Denmark: rate, patient characteristics, and all-cause mortality.
Schmidt SA; Kahlert J; Vestergaard M; Schønheyder HC; Sørensen HT
BMC Infect Dis; 2016 Mar; 16():99. PubMed ID: 26932311
[TBL] [Abstract][Full Text] [Related]
8. β-Blockers and survival among Danish patients with malignant melanoma: a population-based cohort study.
Lemeshow S; Sørensen HT; Phillips G; Yang EV; Antonsen S; Riis AH; Lesinski GB; Jackson R; Glaser R
Cancer Epidemiol Biomarkers Prev; 2011 Oct; 20(10):2273-9. PubMed ID: 21933972
[TBL] [Abstract][Full Text] [Related]
9. The prognostic impact of comorbidities on renal cancer, 1995 to 2006: a Danish population based study.
Lund L; Jacobsen J; Nørgaard M; McLaughlin JK; Blot WJ; Borre M; Sørensen HT
J Urol; 2009 Jul; 182(1):35-40; discussion 40. PubMed ID: 19450859
[TBL] [Abstract][Full Text] [Related]
10. Five-year mortality in colorectal cancer patients with ulcerative colitis or Crohn's disease: a nationwide population-based cohort study.
Ording AG; Horváth-Puhó E; Erichsen R; Long MD; Baron JA; Lash TL; Sørensen HT
Inflamm Bowel Dis; 2013; 19(4):800-5. PubMed ID: 23435402
[TBL] [Abstract][Full Text] [Related]
11. Comorbid diseases interact with breast cancer to affect mortality in the first year after diagnosis--a Danish nationwide matched cohort study.
Ording AG; Garne JP; Nyström PM; Frøslev T; Sørensen HT; Lash TL
PLoS One; 2013; 8(10):e76013. PubMed ID: 24130755
[TBL] [Abstract][Full Text] [Related]
12. Trends in incidence and survival of cutaneous malignant melanoma in Estonia: a population-based study.
Padrik P; Valter A; Valter E; Baburin A; Innos K
Acta Oncol; 2017 Jan; 56(1):52-58. PubMed ID: 27796149
[TBL] [Abstract][Full Text] [Related]
13. Incidence and survival in patients with cutaneous melanoma by morphology, anatomical site and TNM stage: a Danish Population-based Register Study 1989-2011.
Bay C; Kejs AM; Storm HH; Engholm G
Cancer Epidemiol; 2015 Feb; 39(1):1-7. PubMed ID: 25468643
[TBL] [Abstract][Full Text] [Related]
14. Trends in melanoma in the elderly in Denmark, 1980-2012.
Hoejberg L; Gad D; Gyldenkerne N; Bastholt L;
Acta Oncol; 2016; 55 Suppl 1():52-8. PubMed ID: 26785326
[TBL] [Abstract][Full Text] [Related]
15. Comorbidity in Patients With Small-Cell Lung Cancer: Trends and Prognostic Impact.
Aarts MJ; Aerts JG; van den Borne BE; Biesma B; Lemmens VE; Kloover JS
Clin Lung Cancer; 2015 Jul; 16(4):282-91. PubMed ID: 25572007
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors in soft tissue sarcoma.
Maretty-Nielsen K
Dan Med J; 2014 Nov; 61(11):B4957. PubMed ID: 25370967
[TBL] [Abstract][Full Text] [Related]
17. Role of comorbidity on survival after radiotherapy and chemotherapy for nonsurgically treated lung cancer.
Mellemgaard A; Lüchtenborg M; Iachina M; Jakobsen E; Green A; Krasnik M; Møller H
J Thorac Oncol; 2015 Feb; 10(2):272-9. PubMed ID: 25371078
[TBL] [Abstract][Full Text] [Related]
18. Comorbidity and the increased mortality after hospitalization for stroke: a population-based cohort study.
Corraini P; Szépligeti SK; Henderson VW; Ording AG; Horváth-Puhó E; Sørensen HT
J Thromb Haemost; 2018 Feb; 16(2):242-252. PubMed ID: 29171148
[TBL] [Abstract][Full Text] [Related]
19. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
[TBL] [Abstract][Full Text] [Related]
20. Prostate cancer, comorbidity, and the risk of venous thromboembolism: A cohort study of 44,035 Danish prostate cancer patients, 1995-2011.
Ording AG; Horváth-Puhó E; Lash TL; Ehrenstein V; Borre M; Vyberg M; Sørensen HT
Cancer; 2015 Oct; 121(20):3692-9. PubMed ID: 26149752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
